Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
€
2.42
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab quantity
Add to cart
SKU:
product-article-16322
Category:
General
Description
Description
PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
Related products
Article: Calendar of events
€
2.42
Add to cart
Article: Highlights in squamous cell carcinoma of the head and neck
€
2.42
Add to cart
Article: INTRODUCTION
€
2.42
Add to cart
1 year access Online Belgian Journal of Hematology (BJH)
€
43.60
Add to cart